Ion Arocena – General Manager, AseBio, Spain

AseBio is the association promoting the development of the Spanish biotechnology industry. Its general manager, Ion Arocena, lays out the main priorities for the country’s sector, including the need to reevaluate public funding mechanisms at a national and European level, and provides an explanation for Spain’s leadership in clinical trials and their position as a scientific publication powerhouse, ranking 8th globally.  
While the performance of the Spanish R&I system still lags behind the EU average in many indicators, its biotech ecosystem has been able to mature, growing significantly to have almost 800 companies
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report